Electronic Patient-Reported Outcome–Based Symptom Management Versus Usual Care After Lung Cancer Surgery: Long-Term Results of a Multicenter, Randomized, Controlled Trial
Journal of Clinical Oncology · 04.04.2024
DOI: 10.1200/jco.23.01854 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Clinical Oncology, online erschienen am 04.04.2024. Verfasst von Wei Dai und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated C…. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Lung Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported. We previously reported superior symptom control of electronic patient-reported outcome (ePRO)–based symptom management after lung cancer surgery for up to 1 month postdischarge. Here, we present the long-term results (1-12 months) of this multicenter, randomized trial, where patients were assigned 1:1 to receive postoperative ePRO-based symptom management or usual care daily postsurgery, twice weekly postdischarge until 1 month, and at 3, 6, 9, and 12 months postdischarge. Long-term patient-reported outcomes were assessed with MD Anderson Symptom Inventory-Lung Cancer module. Per-protocol analyses were performed with 55 patients in the ePRO group and 57 in the usual care group. At 12 months postdischarge, the ePRO group reported significantly fewer symptom threshold events (any of the five target symptom scored ≥4; median [IQR], 0 [0-0] v 0 [0-1]; P = .040) than the usual care group. From 1 to 12 months postdischarge, the ePRO group consistently reported significantly lower composite scores for physical interference (estimate, –0.86 [95% CI, –1.32 to –0.39]) and affective interference (estimate, –0.70 [95% CI, –1.14 to –0.26]). Early intensive ePRO-based symptom management after lung cancer surgery reduced symptom burden and improved functional status for up to 1 year postdischarge, supporting its integration into standard care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of C…
- Chengdu Center for Disease Control & Prevention, Chengdu, Sichuan, China.
- College of Public Health, Chongqing Medical University, Chongqing, China.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Section of Patient Centred Outcomes Research, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.
ORCID-Profile: Wei Dai, Yaqin Wang, Jia Liao, Xing Wei, Yangjun Liu, Xin Shelley Wang, Cecilia Pompili, Bangrong Cao, Qifeng Wang, Bo Tian, Qiang Li, Qiuling Shi
Zitieren
APA
Dai, W., Wang, Y., Liao, J., Wei, X., Dai, Z., Xu, W., Liu, Y., Wang, X. S., Pompili, C., Yu, H., Pu, Y., Zhao, Y., Cao, B., Wang, Q., Feng, W., Zhang, Y., Liu, F., Deng, Y., Zhou, J., …, & Shi, Q. (2024). Electronic Patient-Reported Outcome–Based Symptom Management Versus Usual Care After Lung Cancer Surgery: Long-Term Results of a Multicenter, Randomized, Controlled Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco.23.01854
Vancouver
Dai W, Wang Y, Liao J, Wei X, Dai Z, Xu W, et al. Electronic Patient-Reported Outcome–Based Symptom Management Versus Usual Care After Lung Cancer Surgery: Long-Term Results of a Multicenter, Randomized, Controlled Trial. Journal of Clinical Oncology. 2024. doi:10.1200/jco.23.01854
BibTeX
@article{Dai2024,
author = {Dai, Wei and Wang, Yaqin and Liao, Jia and Wei, Xing and Dai, Zhen and Xu, Wei and Liu, Yangjun and Wang, Xin Shelley and Pompili, Cecilia and Yu, Hongfan and Pu, Yang and Zhao, Yuqian and Cao, Bangrong and Wang, Qifeng and Feng, Wenhong and Zhang, Yuanqiang and Liu, Fang and Deng, Yuanle and Zhou, Jin and Li, Juan and Xie, Shaohua and Xiang, Run and Wang, Xiang and Tian, Bo and Yang, Xiaozun and Hu, Bin and Liu, Xiaoqin and Xie, Tianpeng and Yang, Xiaojun and Zhuang, Xiang and Qiao, Guibin and Li, Qiang and Shi, Qiuling},
title = {Electronic Patient-Reported Outcome–Based Symptom Management Versus Usual Care After Lung Cancer Surgery: Long-Term Results of a Multicenter, Randomized, Controlled Trial},
journal = {Journal of Clinical Oncology},
year = {2024},
doi = {10.1200/jco.23.01854}
}
EUVIMED